Literature DB >> 19797698

Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale.

Keun-Sik Hong1, Jeffrey L Saver.   

Abstract

BACKGROUND AND
PURPOSE: The modified Rankin Scale (mRS) categorizes poststroke disability among 7 broad, ordinal grades, but the interval distances between these levels are spaced along the disability spectrum have not been previously investigated.
METHODS: We used the person trade-off procedure developed by the World Health Organization Global Burden of Disease Project (WHO-GBDP) to generate disability weights (DWs) ranging from 0 (normal) to 1 (dead) for each of 7 mRS grades. The ratings of an international, 9-member panel of stroke experts were combined by a modified Delphi process.
RESULTS: DWs (95% CI) were 0 for mRS 0, 0.046 (0.004 to 0.088) for mRS 1, 0.212 (0.175 to 0.250) for mRS 2, 0.331 (0.292 to 0.371) for mRS 3, 0.652 (0.625 to 0.678) for mRS 4, 0.944 (0.873 to 1.015) for mRS 5, and 1.0 for mRS 6. DWs of adjacent mRS levels were significantly different (P<0.001 for all). Coefficients of variation showed a high degree of consensus for DWs among panel members. DWs placed each of the 5 intermediate mRS states in different disability class levels of the WHO-GBDP anchor conditions and identified natural clusters to use when reducing the mRS to fewer categories.
CONCLUSIONS: Formal DW assignment confirms that the mRS is an ordered but unequally spaced scale. The availability of DWs for each mRS level now permits direct comparison of each poststroke outcome state with the outcomes of hundreds of other diseases in the WHO-GBDP and the expression of stroke burden in different populations by using the uniform metric of disability-adjusted life-years lost.

Entities:  

Mesh:

Year:  2009        PMID: 19797698      PMCID: PMC2788070          DOI: 10.1161/STROKEAHA.109.561365

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study.

Authors:  Dawn Kleindorfer; Joseph Broderick; Jane Khoury; Matthew Flaherty; Daniel Woo; Kathleen Alwell; Charles J Moomaw; Alexander Schneider; Rosie Miller; Rakesh Shukla; Brett Kissela
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

2.  Incidence and trends of stroke and its subtypes in China: results from three large cities.

Authors:  Bin Jiang; Wen-zhi Wang; Honglei Chen; Zhen Hong; Qi-dong Yang; Sheng-ping Wu; Xiao-li Du; Qiu-ju Bao
Journal:  Stroke       Date:  2005-11-23       Impact factor: 7.914

3.  Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke.

Authors:  G P Samsa; R A Reutter; G Parmigiani; M Ancukiewicz; P Abrahamse; J Lipscomb; D B Matchar
Journal:  J Clin Epidemiol       Date:  1999-03       Impact factor: 6.437

4.  Quality of life after cerebrovascular stroke: a systematic study of patients' preferences for different functional outcomes.

Authors:  S Hallan; A Asberg; B Indredavik; T E Widerøe
Journal:  J Intern Med       Date:  1999-09       Impact factor: 8.989

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Functional outcome 3 months after stroke predicts long-term survival.

Authors:  Marie Eriksson; Bo Norrving; Andreas Terént; Birgitta Stegmayr
Journal:  Cerebrovasc Dis       Date:  2008-03-17       Impact factor: 2.762

7.  Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.

Authors:  B F Gage; A B Cardinalli; G W Albers; D K Owens
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

8.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  Association between disability measures and healthcare costs after initial treatment for acute stroke.

Authors:  Jesse Dawson; Jennifer S Lees; Tou-Pin Chang; Matthew R Walters; Myzoon Ali; Stephen M Davis; Hans-Christoph Diener; Kennedy R Lees
Journal:  Stroke       Date:  2007-04-19       Impact factor: 7.914

10.  Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.

Authors:  Andrei V Alexandrov; Carlos A Molina; James C Grotta; Zsolt Garami; Shiela R Ford; Jose Alvarez-Sabin; Joan Montaner; Maher Saqqur; Andrew M Demchuk; Lemuel A Moyé; Michael D Hill; Anne W Wojner
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

View more
  56 in total

1.  Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories.

Authors:  Srikant Rangaraju; Diogo Haussen; Raul G Nogueira; Fadi Nahab; Michael Frankel
Journal:  Interv Neurol       Date:  2016-11-16

2.  Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation.

Authors:  Matthew A Pappas; Geoffrey D Barnes; Sandeep Vijan
Journal:  J Gen Intern Med       Date:  2019-01-08       Impact factor: 5.128

3.  Diagnostic imaging in the management of patients with possible cerebral venous thrombosis: a cost-effectiveness analysis.

Authors:  Dennis M Hedderich; José M Ferro; Wolfgang G Kunz
Journal:  Neuroradiology       Date:  2019-07-10       Impact factor: 2.804

Review 4.  Early decompressive craniectomy for malignant cerebral infarction: Meta-analysis and clinical decision algorithm.

Authors:  Christopher D Streib; Linda M Hartman; Bradley J Molyneaux
Journal:  Neurol Clin Pract       Date:  2016-10

Review 5.  New stent retriever devices.

Authors:  N C Beadell; Helmi Lutsep
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

6.  Stroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in Stroke.

Authors:  Kennedy R Lees; Pooja Khatri
Journal:  Stroke       Date:  2016-07-12       Impact factor: 7.914

7.  Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis.

Authors:  Keun-Sik Hong; Jeffrey L Saver; Dong-Wha Kang; Hee-Joon Bae; Kyung-Ho Yu; Jaseong Koo; Moon-Ku Han; Yong-Jin Cho; Jong-Moo Park; Byung-Chul Lee
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

Review 8.  Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

Authors:  Joseph P Broderick; Opeolu Adeoye; Jordan Elm
Journal:  Stroke       Date:  2017-06-16       Impact factor: 7.914

9.  Trade-Offs in Quality-of-Life Assessment Between the Modified Rankin Scale and Neuro-QoL Measures.

Authors:  Robert L Askew; Carmen E Capo-Lugo; Rajbeer Sangha; Andrew Naidech; Shyam Prabhakaran
Journal:  Value Health       Date:  2020-09-01       Impact factor: 5.725

10.  Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.

Authors:  Jeffrey L Saver; Tudor G Jovin; Wade S Smith; Gregory W Albers; Jean-Claude Baron; Johannes Boltze; Joseph P Broderick; Lisa A Davis; Andrew M Demchuk; Salvatore DeSena; Jens Fiehler; Philip B Gorelick; Werner Hacke; Bill Holt; Reza Jahan; Hui Jing; Pooja Khatri; Chelsea S Kidwell; Kennedy R Lees; Michael H Lev; David S Liebeskind; Marie Luby; Patrick Lyden; J Thomas Megerian; J Mocco; Keith W Muir; Howard A Rowley; Richard M Ruedy; Sean I Savitz; Vitas J Sipelis; Samuel K Shimp; Lawrence R Wechsler; Max Wintermark; Ona Wu; Dileep R Yavagal; Albert J Yoo
Journal:  Stroke       Date:  2013-11-05       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.